Emergency surgical care in the US health system has in the past considered the roles of the hospitalist and surgicalist. Both relate to the care of in-patients, though a surgicalist is a highly trained, board-certified surgeon who provides emergency surgical care within a dedicated hospital setting.
Dr Lynette Scherer In conversation with Mike Lesner talks about trauma being the leading cause of death for under 40 year olds in
the US, giving rise to the need to deliver trauma care earlier and more efficiently.
As a trauma surgeon and CEO of Surgical Affiliates Management Group, Inc (or known as SAMGI), Dr Scherer’s organisation addresses variations and gaps in emergency surgical care. The work has led to improvements in care, financial performance of hospitals and clinician satisfaction levels.
The universal nature of the SAMGI emergency surgical services model, has been successful across the US with potential for health systems in other countries to also adopt.
In concluding the talk, Dr Scherer discusses the key roles and activities in implementing and getting acceptance on a new emergency surgery care model. This includes benefits for the patient, hospital and surgeon.
-
Clinical research and trials in Australia and New Zealand
Clinical research and trials in the Australia and New Zealand region offer foreign companies an opportunity to collaborate with local institutions, tap into diverse patient populations, access high-quality healthcare infrastructure, and gain regulatory approvals, enabling them to expand their market reach and accelerate the development of innovative medical interventions.
Clinical trials continued in Australia and New Zealand during lockdown, thanks to collaboration between industry and government, allowing the region to attract trials from other countries.
-
Lifelong research into Cannabis
Mechoulam was possibly the most significant academic to shed light on the active principles of the cannabis plant back in the 1960s, when his work at the Weizmann Institute led to the discovery of the human endo-cannabinoid system, giving him the title the “Godfather of cannabis research”. In a recent Global Health Talk with Michael Lesner, Professor Mechoulam reflects on his lifelong work in cannabis research.
-
Australia’s digital health push into new national markets
Infection rates following surgical procedure vary across countries, however the causes and the ranges of variation are not well understood.
The causes of the infections are not as high as would be assumed on the surgical procedure, but co-morbidity and lifestyle choices including alcohol consumption may exacerbate risk. As Dr Edmiston states, there are a myriad of causes, and funding is limited in many countries. However there are some solutions, where goals, performance tracking against the goals and better communication is needed.
